Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Publication | Closed Access

DOI

Citations

References

2013

Year

Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, Özge Gümüşay, Adem Dayan, Lütfiye Demir, Çağlayan Geredeli, Murat Koçer, Ülkü Yalçıntaş Arslan, Ali̇ İnal,

Breast Cancer

Breast OncologyCapecitabine Combination TherapyMedicineBrain MetastasisClinical OutcomesBreast CancerCancer TreatmentOncologyRadiation OncologyHealth Sciences